Suzanne Sawochka Hooper
2017
In 2017, Suzanne Sawochka Hooper earned a total compensation of $3.3M as Executive Vice President and GC at Jazz Pharmaceuticals, a 17% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $350,000 |
|---|---|
| Option Awards | $1,060,658 |
| Salary | $546,154 |
| Stock Awards | $1,361,800 |
| Other | $10,722 |
| Total | $3,329,334 |
Hooper received $1.4M in stock awards, accounting for 41% of the total pay in 2017.
Hooper also received $350K in non-equity incentive plan, $1.1M in option awards, $546.2K in salary and $10.7K in other compensation.
Rankings
In 2017, Suzanne Sawochka Hooper's compensation ranked 3,197th out of 14,666 executives tracked by ExecPay. In other words, Hooper earned more than 78.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,197 out of 14,666 | 78th |
Division Manufacturing | 1,099 out of 5,768 | 81st |
Major group Chemicals And Allied Products | 303 out of 2,074 | 85th |
Industry group Drugs | 233 out of 1,730 | 87th |
Industry Pharmaceutical Preparations | 184 out of 1,329 | 86th |
Source: SEC filing on June 15, 2018.
Hooper's colleagues
We found five more compensation records of executives who worked with Suzanne Sawochka Hooper at Jazz Pharmaceuticals in 2017.
2017
Bruce Cozadd
Jazz Pharmaceuticals
Chief Executive Officer
2017
Matthew Young
Jazz Pharmaceuticals
Chief Financial Officer
2017
Russell Cox
Jazz Pharmaceuticals
Chief Operating Officer
2017
Karen Smith
Jazz Pharmaceuticals
Chief Marketing Officer
2017
Michael Miller
Jazz Pharmaceuticals